Mode
Text Size
Log in / Sign up

Recurrent Pregnancy Loss

9 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Recurrent Pregnancy Loss

3 trials tracked for Recurrent Pregnancy Loss: 1 in phase 3 or 4.

3Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 2 1 Other / NA 1
  1. Phase 4 Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial Completed
  2. Phase 2 Assessing the Endometrial Environment in Recurrent Pregnancy Loss and Unexplained Infertility Completed
  3. N/A Low Plasma Mannose Binding Lectin (p-MBL) Level is a Risk Factor for Recurrent Pregnancy Loss (RPL) Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Recurrent Pregnancy Loss

How does the Elgheriany Reproductive Immunology Framework explain immune issues in recurrent pregnancy loss?

The Elgheriany Reproductive Immunology Framework explains recurrent pregnancy loss by focusing on specific immune failures rather than assuming all cases are immune-related, emphasizing precise timing and interpretation of immune data.

Full answer →
What are the main causes or categories of recurrent pregnancy loss found in the meta-analysis?

The meta-analysis found that the largest category of recurrent pregnancy loss is unexplained (37%), followed by acquired thrombophilia, uterine anomalies, endocrine disorders, and other causes.

Full answer →
How does multi-omics profiling help understand recurrent pregnancy loss?

Multi-omics profiling helps understand recurrent pregnancy loss by revealing molecular disruptions in immunity, metabolism, and cell communication that single tests miss.

Full answer →